Further reading

Beckman, J., Greagen, M., Libby, P. (2002) Diabetes and Atherosclerosis. JAMA, 287, 2570-81.

Bjorntrop, P. (1992) Regional obesity, in Obesity. (eds P. Bjorntrop and B.N. Brodoff). J.B. Lippincott Co, New York, pp. 576-86.

Colhoun, H.M., Betteridge, D.J., Durrington, P.N., Hitman, G.A., Neil H.A., Livingstone, S.J., Thomason, M.J., Mackness, M.I., Charlton-Menys, V., Fuller, J.H. (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet, 364, 685-96.

Gray, R., Yudkin, J. (1997) Cardiovascular disease in diabetes mellitus, in Textbook of Diabetes, 2nd edn (eds J. Pickup and G. Williams), Blackwell Science, 57, pp. 1-22.

Hendra, T.J., Yudkin, J.S. (1992) An algorithm for tight glycaemic control in diabetic infarct survivors. Diabetes Res Clin Pract., 16, 213-20.

IDF consensus worldwide definition of the metabolic syndrome. www.idf.org April 2005.

Malmberg, K., Ryden, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., Hildebrandt, P., MacLeod, K., Laakso, M., Torp-Pedersen, C., Waldenstrom, A. (2005) Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J, 26, 650-61.

Malmberg, K. (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ, 314, 1512-15.

Mehta, S.R., Yusuf, S., Diaz, R., Zhu, J., Pais, P., Xavier, D., Paolasso, E., Ahmed, R., Xie, C., Kazmi, K., Tai, J., Orlandini, A., Pogue, J., Liu, L. (2005) Effect of glucose-insulin-potassium infusion on mortality in patients with acute

ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA, 293, 437-46.

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial (2002) Lancet, 360, 7-22.

Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes, 37, 1595.

Sobel, B.E. (2004) Heart disease and diabetes, in: Therapy for Diabetes Mellitus and Related Disorders, 4th edn, American Diabetes Association, (ed. H.E. Lebovitz), pp 465-72.

Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. (2003) Eur Heart J., 24,1601-10.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook


Post a comment